Related references
Note: Only part of the references are listed.Kinase Drug Discovery - What's Next in the Field?
Philip Cohen et al.
ACS CHEMICAL BIOLOGY (2013)
Exploiting the repertoire of CK2 inhibitors to target DYRK and PIM kinases
Giorgio Cozza et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2013)
Novel potent dual inhibitors of CK2 and Pim kinases with antiproliferative activity against cancer cells
Fabrice Pierre et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Structural features underlying the selectivity of the kinase inhibitors NBC and dNBC: role of a nitro group that discriminates between CK2 and DYRK1A
Stefania Sarno et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2012)
Synthesis and Antimicrobial Activities of New Polyhalogenated Benzimidazoles
Agnieszka E. Laudy et al.
JOURNAL OF HETEROCYCLIC CHEMISTRY (2012)
Effects of the CK2 Inhibitors CX-4945 and CX-5011 on Drug-Resistant Cells
Sofia Zanin et al.
PLOS ONE (2012)
Casein Kinase 2α Regulates Multidrug Resistance-Associated Protein 1 Function via Phosphorylation of Thr249
Elzbieta I. Stolarczyk et al.
MOLECULAR PHARMACOLOGY (2012)
Overview of the CCP4 suite and current developments
Martyn D. Winn et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2011)
Unprecedented Selectivity and Structural Determinants of a New Class of Protein Kinase CK2 Inhibitors in Clinical Trials for the Treatment of Cancer
Roberto Battistutta et al.
BIOCHEMISTRY (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
ATP Site-Directed Inhibitors of Protein Kinase CK2: An Update
S. Sarno et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2011)
The oncogenic PIM kinase family regulates drug resistance through multiple mechanisms
Methvin Isaac et al.
DRUG RESISTANCE UPDATES (2011)
For better or for worse: the role of Pim oncogenes in tumorigenesis
Martijn C. Nawijn et al.
NATURE REVIEWS CANCER (2011)
XDS
Wolfgang Kabsch
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
Features and development of Coot
P. Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Paul D. Adams et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
Emergence of protein kinase CK2 as a key target in cancer therapy
Janeen H. Trembley et al.
BIOFACTORS (2010)
CX-4945, an Orally Bioavailable Selective Inhibitor of Protein Kinase CK2, Inhibits Prosurvival and Angiogenic Signaling and Exhibits Antitumor Efficacy
Adam Siddiqui-Jain et al.
CANCER RESEARCH (2010)
New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights
Miriam Lopez-Ramos et al.
FASEB JOURNAL (2010)
PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers
Laurent Brault et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Selectively Nonselective Kinase Inhibition: Striking the Right Balance
Richard Morphy
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2
Giorgio Cozza et al.
BIOCHEMICAL JOURNAL (2009)
From birth to death: The role of protein kinase CK2 in the regulation of cell proliferation and survival
N. A. St-Denis et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Synthesis and Evaluation of Novel Inhibitors of Pim-1 and Pim-2 Protein Kinases
Zuping Xia et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
The selectivity of inhibitors of protein kinase CK2: an update
Mario A. Pagano et al.
BIOCHEMICAL JOURNAL (2008)
The CK2α/CK2β interface of human protein kinase CK2 harbors a binding pocket for small molecules
Jennifer Raaf et al.
CHEMISTRY & BIOLOGY (2008)
The selectivity of protein kinase inhibitors: a further update
Jenny Bain et al.
BIOCHEMICAL JOURNAL (2007)
Gini coefficient: A new way to express selectivity of kinase inhibitors against a family of kinases
Piotr P. Graczyk
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Pharmacological inhibition of protein kinase CK2 reverts the multidrug resistance phenotype of a CEM cell line characterized by high CK2 level
G. Di Maira et al.
ONCOGENE (2007)
Phaser crystallographic software
Airlie J. McCoy et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2007)
Protein kinase CK2 phosphorylates and upregulates Akt/PKB
G Di Maira et al.
CELL DEATH AND DIFFERENTIATION (2005)
2-dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole: a novel powerful and selective inhibitor of protein kinase CK2
MA Pagano et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Protein kinase CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB) induces apoptosis and caspase-dependent degradation of haematopoietic lineage cell-specific protein 1 (HS1) in Jurkat cells
M Ruzzene et al.
BIOCHEMICAL JOURNAL (2002)
Selectivity of 4,5,6,7-tetrabromobenzotriazole, an ATP site-directed inhibitor of protein kinase CK2 ('casein kinase-2')
S Sarno et al.
FEBS LETTERS (2001)
Share Paper
